Match each clinical presentation of infective endocarditis with the most appropriate empiric or targeted antimicrobial regimen.
- A 55-year-old man with native valve endocarditis caused by methicillin-susceptible Staphylococcus aureus (MSSA) and no known drug allergies.Intravenous cefazolin or intravenous nafcillin
- A 68-year-old woman with suspected prosthetic valve endocarditis, presenting with fever and a new murmur 3 months after a surgical aortic valve replacement.Intravenous vancomycin, intravenous gentamicin, and oral rifampin
- A 72-year-old man with native valve endocarditis caused by Enterococcus faecalis and a history of severe chronic kidney disease.Intravenous ampicillin plus intravenous ceftriaxone
- A 45-year-old woman with subacute native valve endocarditis caused by Streptococcus gallolyticus that is highly susceptible to penicillin.Intravenous aqueous crystalline penicillin G or intravenous ceftriaxone (monotherapy)
Cevap
The correct matches are: Native valve MSSA endocarditis pairs with IV cefazolin or nafcillin; early prosthetic valve endocarditis pairs with IV vancomycin, gentamicin, and rifampin; Enterococcal endocarditis in a patient with chronic kidney disease pairs with IV ampicillin plus ceftriaxone; and highly penicillin-susceptible Streptococcus gallolyticus endocarditis pairs with IV penicillin G or ceftriaxone monotherapy.
Each pathogen and clinical scenario in infective endocarditis requires a specific, guideline-directed antimicrobial regimen to ensure bactericidal activity, penetrate biofilms on prostheses, and minimize systemic toxicity.
Adım Adım Çözüm
Anahtar Kavram
Appropriate antimicrobial selection for infective endocarditis depends heavily on the causative pathogen, the presence of prosthetic material (requiring biofilm penetration), and patient-specific comorbidities such as underlying renal dysfunction.